Identification of BRD7 by whole-exome sequencing as a predictor for intermediate-stage hepatocellular carcinoma in patients undergoing TACE.

Kun HuangYanqin WuWenzhe FanYue ZhaoMiao XueHaikuan LiuYiyang TangJiaping Li

Published in: Journal of cancer research and clinical oncology (2023)

BRD7 expression may be an independent risk factor for prognosis in patients with HCC undergoing TACE. Imaging features such as wash-in enhancement are closely related to BRD7 expression.

Keyphrases

poor prognosis
patients undergoing
high resolution
binding protein
long non coding rna
fluorescence imaging
drug induced